Search Within

Eric Smith

Formats
  1. Meeting Abstract (42)
  2. Journal Article (27)
  3. Book Section (3)
  4. Research Letter (2)
  5. Guidelines (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (76)
  2. Department of Medicine (76)
  3. Hematologic Malignancies Research (76)
  4. Hematologic Malignancies, Division of (76)
  5. Myeloma (76)
  6. Survivorship Research (48)

More Groups

People
  1. Sham Mailankody (44)
  2. Carl Landgren (42)
  3. Alexander Lesokhin (38)
  4. Sergio Giralt (38)
  5. Hani Hassoun (36)
  6. Neha Korde (36)

More People

Years
  1. 2025 (1)
  2. 2022 (2)
  3. 2021 (5)
  4. 2020 (13)
  5. 2019 (19)
  6. 2018 (15)

More Years

Publications
  1. Blood (27)
  2. Biology of Blood and Marrow Transplantation (8)
  3. Clinical Lymphoma, Myeloma and Leukemia (7)
  4. Journal of Clinical Oncology (4)
  5. Pocket Oncology (3)
  6. Blood Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Elsevier Inc. (16)
  3. Nature Publishing Group (5)
  4. American Association for Cancer Research (4)
  5. American Society of Clinical Oncology (4)
  6. Wolters Kluwer Health | Lippincott Williams & Wilkins (3)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR T cell therapy for multiple myeloma: Where are we now and where are we headed?
    Journal Article

    Ghosh, A.; Mailankody, S.; Giralt, S. A.; Landgren, C. O.; Smith, E. L.; Brentjens, R. J.
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
    Journal Article

    Lendvai, N.; Tsakos, I.; Devlin, S. M.; Schaffer, W. L.; Hassoun, H.; Lesokhin, A. M.; Landau, H.; Korde, N.; Mailankody, S.; Smith, E.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Development and evaluation of an optimal human single-chain variable fragment-derived BCMA-targeted CAR T cell vector
    Journal Article

    Smith, E. L.; Staehr, M.; Masakayan, R.; Tatake, I. J.; Purdon, T. J.; Wang, X.; Wang, P.; Liu, H.; Xu, Y.; Garrett-Thomson, S. C.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • CARs and other T cell therapies for MM: The clinical experience
    Journal Article

    Danhof, S.; Hudecek, M.; Smith, E. L.
    Best Practice and Research: Clinical Haematology (2018)

    Fulltext@MSK | Save
  • In-situ protein expression analysis of B-cell maturation antigen (BCMA)
    Meeting Abstract

    Jungbluth, A.; Dogan, A.; Frosina, D.; Fayad, M.; Smith, E.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Depth and timing of improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G. L.; Assal, A.; Hsu, M.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • B-cell maturation antigen is exclusively expressed in a wide range of B-cell and plasma cell neoplasm and in a potential therapeutic target for BCMA directed therapies
    Meeting Abstract

    Khattar, P.; Pichardo, J.; Jungbluth, A.; Gao, Q.; Smith, E. L.; Roshal, M.; Dogan, A.
    Blood (2017)

    Fulltext@MSK | Save
  • Development of JCARH125: Optimization of a fully human anti-BCMA CAR for use in the treatment of multiple myeloma
    Meeting Abstract

    Harrington, K.; Wu, R.; Hauskins, C.; Amin, R.; Long, T.; Chen, A.; Rahardjo, A.; Thayer, C.; Navvaro, G.; Myers, M.; more...
    Blood (2017)

    Fulltext@MSK | Save